Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Shares of the digital healthcare platform, which caters to millennials, fell as much as 6.8% before rebounding. The stock then dipped more than 4% in after-hours trading. The selloff followed Hims & Hers' announcement that it had added Eli Lilly's ( LLY ) popular weight-loss drug Zepbound and a generic GLP-1 medication to its platform. The news comes in response to a recent decision by the Food and Drug Administration (FDA), which removed semaglutide — the active ingredient in Novo Nordisk's ( NVO ) Ozempic and Wegovy — from the agency's shortage list. As a result, Hims & Hers will soon have to limit its previous offerings of the drug. Last May, the company began selling compounded semaglutide — an off-brand version of Ozempic — starting at $199 a month . That helped drive the company's total revenue up 69% last year, reaching $1.5 billion. But now that the drug is no longer in short supply , Hims & Hers will only be able to sell personalized and clinically necessary formulat
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now [Yahoo! Finance]Yahoo! Finance
- MEDI&GENE Announces Catalyze Agreement with Lilly to Advance Next-Generation Obesity Therapeutics [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at Daiwa America from a "hold" rating to a "strong-buy" rating.MarketBeat
- Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly [CNBC]CNBC
- Is Eli Lilly a Buy Before 2026? [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 12/16/25 - Form 4
- 12/16/25 - Form 4
- 12/16/25 - Form 4
- LLY's page on the SEC website